Citius Oncology Investigation Underway Amid Fiduciary Duty Concerns.

Monday, Jan 5, 2026 10:34 am ET1min read
CTOR--

Purcell & Lefkowitz LLP is investigating Citius Oncology, Inc. (NASDAQ: CTOR) on behalf of shareholders, seeking to determine if directors breached their fiduciary duties in recent corporate actions. Shareholders can visit the firm's website or contact Robert H. Lefkowitz for more information. Purcell & Lefkowitz LLP represents shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty, and other corporate misconduct.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet